Agenus corporate update and second quarter 2021 financial report

Lexington, mass., aug. 09, 2021 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today provided a corporate update and reported financial results for the second quarter of 2021.
AGEN Ratings Summary
AGEN Quant Ranking